Previous Article | Next Article ![]()
Journal of Clinical Microbiology, April 1999, p. 1210-1212, Vol. 37, No. 4
Departments of Medicine and Clinical
Laboratories, North Shore University Hospital-NYU School of
Medicine, Manhasset, New York
Received 31 August 1998/Returned for modification 6 November
1998/Accepted 15 January 1999
This study compared levels of human immunodeficiency virus type 1 RNA in plasma as measured by the Quantiplex branched-DNA and NucliSens nucleic acid sequence-based amplification assays. RNA was
detectable in 118 of 184 samples (64.13%) by the Quantiplex assay and
in 171 of 184 samples (92.94%) by the NucliSens assay. Regression analysis indicated that a linear relationship existed between the two sets of values (P < 0.0001), although
the Quantiplex and NucliSens values were significantly different
(P < 0.001), with the NucliSens values being
approximately 0.323 log higher. Spearman correlation analysis indicated
that the overall changes in patient viral load patterns were highly
correlative between the two assays: r = 0.912, P < 0.0001. The lower limits of sensitivity were
determined to be approximately 100 copies/ml and 1,200 to 1,400 copies/ml for the NucliSens and Quantiplex assays, respectively.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Comparison of Levels of Human Immunodeficiency Virus Type 1 RNA
in Plasma as Measured by the NucliSens Nucleic Acid Sequence-Based
Amplification and Quantiplex Branched-DNA Assays
*
Corresponding author. Mailing address: North
Shore-LIJ Health System Laboratories, 10 Nevada Dr., Lake Success,
NY 11042. Phone: (516) 719-1079. Fax: (516) 719-1254. E-mail:
cginocch{at}nshs.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»